Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +5.2% | +33.7% | 3 / 3 | -1.3% | +5.37 pp | +1.38 pp | +21.8% | 0.00 | 6.55 | 207 | −1,3% | 46,9 | +5,2% | 6.55 | 9.93 | −34,1% |
| Pts | 0 | 4 | 12 | 0 | 12 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 61.200 (close price on 2026-10-19)EPS (TTM): 9.350
Financial charts
1.Revenue & growth
VND bn207Q2/26
1.Revenue & growth
VND bn207Q2/26
2.Profit & growth
VND bn46,9Q2/26
3.Profit mix (Penman)
VND bn216Q2/26
4.Margins & cost structure
%51.9%Q2/26
5.Returns & cash cycle
% · days714%Q2/26
6.Earnings quality & cash
VND bn102Q2/26
7.Asset structure
VND bn967Q2/26
8.Funding & debt health
VND bn · times967Q2/26
9.Revenue backlog
VND bn25,9Q2/26
10.Valuation
times · %6,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.540Q2/26
Adjusted EPS growth, latest quarter
5.2%
Average adjusted EPS growth, 3 quarters
33.7%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26